|
1
|
Jemal A, Bray F, Center MM, Ferlay J, Ward
E and Forman D: Global cancer statistics. CA Cancer J Clin.
61:69–90. 2011. View Article : Google Scholar
|
|
2
|
Hartgrink HH, Jansen EP, van Grieken NC
and van de Velde CJ: Gastric cancer. Lancet. 374:477–490. 2009.
View Article : Google Scholar
|
|
3
|
Derynck R and Akhurst RJ: Differentiation
plasticity regulated by TGF-beta family proteins in development and
disease. Nat Cell Biol. 9:1000–1004. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Saito H, Tsujitani S, Oka S, et al: The
expression of transforming growth factor-beta1 is significantly
correlated with the expression of vascular endothelial growth
factor and poor prognosis of patients with advanced gastric
carcinoma. Cancer. 86:1455–1462. 1999. View Article : Google Scholar
|
|
5
|
Maehara Y, Kakeji Y, Kabashima A, et al:
Role of transforming growth factor-beta 1 in invasion and
metastasis in gastric carcinoma. J Clin Oncol. 17:607–614.
1999.PubMed/NCBI
|
|
6
|
Ijichi H, Ikenoue T, Kato N, et al:
Systematic analysis of the TGF-beta-Smad signaling pathway in
gastrointestinal cancer cells. Biochem Biophys Res Commun.
289:350–357. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Wang KS, Hu ZL, Li JH, Xiao DS and Wen JF:
Enhancement of metastatic and invasive capacity of gastric cancer
cells by transforming growth factor-beta1. Acta Biochim Biophys Sin
(Shanghai). 38:179–186. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Parajuli P, Joshee N, Rimando AM, Mittal S
and Yadav AK: In vitro antitumor mechanisms of various Scutellaria
extracts and constituent flavonoids. Planta Med. 75:41–48. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Li-Weber M: New therapeutic aspects of
flavones: the anticancer properties of Scutellaria and its main
active constituents Wogonin, Baicalein and Baicalin. Cancer Treat
Rev. 35:57–68. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Wang L, Ling Y, Chen Y, et al: Flavonoid
baicalein suppresses adhesion, migration and invasion of MDA-MB-231
human breast cancer cells. Cancer Lett. 297:42–48. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Wu B, Li J, Huang D, et al: Baicalein
mediates inhibition of migration and invasiveness of skin carcinoma
through Ezrin in A431 cells. BMC Cancer. 11:5272011. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Wu JY, Tsai KW, Li YZ, et al:
Anti-bladder-tumor effect of baicalein from Scutellaria
baicalensis Georgi and its application in vivo. Evid Based
Complement Alternat Med. 2013:5797512013.PubMed/NCBI
|
|
13
|
Chiu YW, Lin TH, Huang WS, et al:
Baicalein inhibits the migration and invasive properties of human
hepatoma cells. Toxicol Appl Pharmacol. 255:316–326. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Zhang Y, Song L, Cai L, Wei R, Hu H and
Jin W: Effects of baicalein on apoptosis, cell cycle arrest,
migration and invasion of osteosarcoma cells. Food Chem Toxicol.
53:325–333. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Picon A, Gold LI, Wang J, Cohen A and
Friedman E: A subset of metastatic human colon cancers expresses
elevated levels of transforming growth factor beta1. Cancer
Epidemiol Biomarkers Prev. 7:497–504. 1998.
|
|
16
|
Fransvea E, Angelotti U, Antonaci S and
Giannelli G: Blocking transforming growth factor-beta up-regulates
E-cadherin and reduces migration and invasion of hepatocellular
carcinoma cells. Hepatology. 47:1557–1566. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Takano S, Kanai F, Jazag A, et al: Smad4
is essential for down-regulation of E-cadherin induced by TGF-beta
in pancreatic cancer cell line PANC-1. J Biochem. 141:345–351.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Wiercinska E, Naber HP, Pardali E, van der
Pluijm G, van Dam H and ten Dijke P: The TGF-β/Smad pathway induces
breast cancer cell invasion through the up-regulation of matrix
metalloproteinase 2 and 9 in a spheroid invasion model system.
Breast Cancer Res Treat. 128:657–666. 2011.
|
|
19
|
Deckers M, van Dinther M, Buijs J, et al:
The tumor suppressor Smad4 is required for transforming growth
factor beta-induced epithelial to mesenchymal transition and bone
metastasis of breast cancer cells. Cancer Res. 66:2202–2209. 2006.
View Article : Google Scholar
|
|
20
|
Shiou SR, Datta PK, Dhawan P, et al:
Smad4-dependent regulation of urokinase plasminogen activator
secretion and RNA stability associated with invasiveness by
autocrine and paracrine transforming growth factor-beta. J Biol
Chem. 281:33971–33981. 2006. View Article : Google Scholar
|
|
21
|
Araki K, Shimura T, Suzuki H, et al:
E/N-cadherin switch mediates cancer progression via TGF-β-induced
epithelial-to-mesenchymal transition in extrahepatic
cholangiocarcinoma. Br J Cancer. 105:1885–1893. 2011.PubMed/NCBI
|
|
22
|
Cheng JC, Auersperg N and Leung PC:
TGF-beta induces serous borderline ovarian tumor cell invasion by
activating EMT but triggers apoptosis in low-grade serous ovarian
carcinoma cells. PLoS One. 7:e424362012. View Article : Google Scholar
|
|
23
|
Dai M, Al-Odaini AA, Fils-Aimé N, et al:
Cyclin D1 cooperates with p21 to regulate TGFβ-mediated breast
cancer cell migration and tumor local invasion. Breast Cancer Res.
15:R492013.PubMed/NCBI
|
|
24
|
Derycke LD and Bracke ME: N-cadherin in
the spotlight of cell-cell adhesion, differentiation,
embryogenesis, invasion and signalling. Int J Dev Biol. 48:463–476.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Satelli A and Li S: vimentin in cancer and
its potential as a molecular target for cancer therapy. Cell Mol
Life Sci. 68:3033–3046. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Jia B, Liu H, Kong Q and Li B:
Overexpression of ZEB1 associated with metastasis and invasion in
patients with gastric carcinoma. Mol Cell Biochem. 366:223–229.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Okugawa Y, Toiyama Y, Tanaka K, et al:
Clinical significance of Zinc finger E-box Binding homeobox 1
(ZEB1) in human gastric cancer. J Surg Oncol. 106:280–285. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Dai YH, Tang YP, Zhu HY, et al: ZEB2
promotes the metastasis of gastric cancer and modulates epithelial
mesenchymal transition of gastric cancer cells. Dig Dis Sci.
57:1253–1260. 2012. View Article : Google Scholar
|
